
    
      CAPTURE is a prospective, single-arm, multicenter trial, designed to evaluate the safety,
      feasibility and tolerability of the Vineâ„¢ permanent carotid filter. The trial will enroll up
      to 30 patients, and will be conducted in up to five sites worldwide. All enrolled patients
      will be invited for non-invasive follow-up tests and clinical evaluations according to the
      study protocol.
    
  